Search Results 701-710 of 16635 for ������������KA���:ZA31���24������ ���������������������������������

1. AI assist the clinician with patient queries? - Mayo Clinic

   Rochester, Minnesota: 24-011622. About this study. The purpose of this study will be looking at the feasibility of using AI to generate individualized ...

2. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Cediranib maleate and olaparib may stop the growth of tumor cells by blocking enzymes needed for cell growth. Drugs used in chemotherapy work in different ways ...

3. Head and neck cancers - Doctors and departments - Mayo Clinic

   Head & Neck Cancer Discussions. thefarmer · Ten years after throat radiation and ongoing damage. 19 Replies Thu, Apr 24, 2025.

4. Head and neck cancers - Doctors and departments - Mayo Clinic

   568 Replies Thu, Apr 24, 2025. See more discussions. Related. Head and Neck Cancer Transoral Surgery. Associated Procedures. Chemotherapy · Home enteral ...

5. Publications - Jay-Sheree A. Akambase, M.D., M.P.H. - Mayo Clinic

   Huang L, Huschka TR, Barwise AK, Allen JP, Wolfersteig W, Hamm K, Cardenas LD, Phelan SM, Allyse MA. Psychological reactance, misinformation, and distrust: ...

6. Senyo Health With Substance Use Disorder (SUD) In Primary Care - Mayo Clinic

   Rochester, Minnesota: 24-007758. NCT ID: NCT06743282. About this study. The purpose of this study is to examine the barriers, facilitators, and optimal ...

7. Crossover Feasibility Study of Portable AP Device with Zone-MPC and HMS and Adapted I:C and Basal Insulin - Mayo Clinic

   The study consists of an evaluation of the Artificial Pancreas device system during two 24-27.5-hour closed-loop phases in an outpatient/hotel environment.

8. Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism - Mayo Clinic

   ... 24 hours as compared with the current once daily dosing regimen of marketed ... Urinary calcium excretion ≥200 mg (5mmol)/24h, based on a 24-hour ...

9. Transcutaneous Delivery Using Syringe and Device-Assisted Methods in Ex-Vivo Human Skin - Mayo Clinic

   Jacksonville, Florida: 24-013695. About this study. The purpose of this study is evaluate the efficacy of transcutaneous delivery of tattoo ink in ex-vivo ...

10. Oncology (Medical) - Clinical trials - Mayo Clinic

    Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...